Thrivent Financial for Lutherans’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-37,534
| Closed | -$391K | – | 2431 |
|
|
2023
Q2 | $391K | Sell |
37,534
-1,248
| -3% | -$12K | ﹤0.01% | 2263 |
|
|
2023
Q1 | $401K | Sell |
38,782
-1,333
| -3% | -$17.1K | ﹤0.01% | 2213 |
|
|
2022
Q4 | $552K | Sell |
40,115
-169
| -0.4% | -$2.35K | ﹤0.01% | 2068 |
|
|
2022
Q3 | $824K | Buy |
40,284
+2,184
| +6% | +$47.9K | ﹤0.01% | 1799 |
|
|
2022
Q2 | $737K | Buy |
38,100
+6,581
| +21% | +$135K | ﹤0.01% | 1888 |
|
|
2022
Q1 | $679K | Buy |
31,519
+65
| +0.2% | +$1.48K | ﹤0.01% | 2046 |
|
|
2021
Q4 | $868K | Buy |
31,454
+379
| +1% | +$10.5K | ﹤0.01% | 1938 |
|
|
2021
Q3 | $806K | Sell |
31,075
-102
| -0.3% | -$2.73K | ﹤0.01% | 1956 |
|
|
2021
Q2 | $846K | Sell |
31,177
-9
| -0% | -$220 | ﹤0.01% | 1947 |
|
|
2021
Q1 | $730K | Sell |
31,186
-218
| -0.7% | -$4.41K | ﹤0.01% | 2047 |
|
|
2020
Q4 | $481K | Hold |
31,404
| – | – | ﹤0.01% | 2147 |
|
|
2020
Q3 | $379K | Sell |
31,404
-125
| -0.4% | -$1.19K | ﹤0.01% | 2093 |
|
|
2020
Q2 | $321K | Hold |
31,529
| – | – | ﹤0.01% | 2096 |
|
|
2020
Q1 | $329K | Buy |
31,529
+1,574
| +5% | +$19.8K | ﹤0.01% | 1934 |
|
|
2019
Q4 | $480K | Sell |
29,955
-10,336
| -26% | -$158K | ﹤0.01% | 1911 |
|
|
2019
Q3 | $742K | Buy |
40,291
+11,156
| +38% | +$218K | ﹤0.01% | 1609 |
|
|
2019
Q2 | $574K | Buy |
29,135
+749
| +3% | +$15.3K | ﹤0.01% | 1747 |
|
|
2019
Q1 | $649K | Buy |
28,386
+2,026
| +8% | +$44K | ﹤0.01% | 1656 |
|
|
2018
Q4 | $531K | Buy |
26,360
+579
| +2% | +$12K | ﹤0.01% | 1523 |
|
|
2018
Q3 | $560K | Buy |
25,781
+533
| +2% | +$11.8K | ﹤0.01% | 1638 |
|
|
2018
Q2 | $562K | Buy |
25,248
+1,525
| +6% | +$31.2K | ﹤0.01% | 1624 |
|
|
2018
Q1 | $409K | Buy |
23,723
+883
| +4% | +$14.7K | ﹤0.01% | 1739 |
|
|
2017
Q4 | $380K | Buy |
22,840
+450
| +2% | +$7.68K | ﹤0.01% | 1807 |
|
|
2017
Q3 | $383K | Buy |
22,390
+1,780
| +9% | +$29.9K | ﹤0.01% | 1688 |
|
|
2017
Q2 | $334K | Buy |
20,610
+2,430
| +13% | +$38.4K | ﹤0.01% | 1716 |
|
|
2017
Q1 | $315K | Sell |
18,180
-48,420
| -73% | -$810K | ﹤0.01% | 1735 |
|
|
2016
Q4 | $1.12M | Buy |
66,600
+51,830
| +351% | +$864K | 0.01% | 1091 |
|
|
2016
Q3 | $259K | Buy |
14,770
+1,910
| +15% | +$31K | ﹤0.01% | 1757 |
|
|
2016
Q2 | $185K | Buy |
12,860
+840
| +7% | +$10.5K | ﹤0.01% | 1817 |
|
|
2016
Q1 | $148K | Buy |
12,020
+610
| +5% | +$6.74K | ﹤0.01% | 1800 |
|
|
2015
Q4 | $139K | Buy |
11,410
+560
| +5% | +$6.9K | ﹤0.01% | 1802 |
|
|
2015
Q3 | $143K | Buy |
10,850
+800
| +8% | +$12.1K | ﹤0.01% | 1667 |
|
|
2015
Q2 | $165K | Buy |
+10,050
| New | +$167K | ﹤0.01% | 1648 |
|
Other funds holding ANGO
SFM
Thrivent Financial for Lutherans's ANGO Position: Q3 2023 in Review
Thrivent Financial for Lutherans sold out of AngioDynamics (ANGO) in Q3 2023, closing a stake of 37,534 shares — an estimated $391K sold.
Thrivent Financial for Lutherans first reported a position in ANGO in Q2 2015 and held it in 33 quarters. The position peaked at $1.12M in Q4 2016. 154 funds tracked by Wall St. Rank hold ANGO as of Q3 2023.
- Thrivent Financial for Lutherans reported no remaining AngioDynamics position as of Q3 2023 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 37,534 AngioDynamics shares in Q3 2023, an estimated $391K.
- Thrivent Financial for Lutherans first reported a position in AngioDynamics in Q2 2015 and held it in 33 quarters.
- Thrivent Financial for Lutherans's AngioDynamics position peaked at $1.12M in Q4 2016.
- 154 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2023.
Based on Thrivent Financial for Lutherans's 13F filing for Q3 2023, filed 14 Nov 2023.